Spirovant Sciences
Business Services · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3675 Market St Ste 200, Philadelphia, Pe...Phone Number
(267) 244-8206Website
www.spirovant.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Spirovant Sciences
Spirovant Sciences is a biotechnology company specializing in the development of gene therapies for cystic fibrosis and other genetic lung diseases. The company utilizes its proprietary Adeno-Associated Virus (AAV) + Augmenter platform to create innovative treatments that address historical barriers in effective genetic therapies. With a focus on patients with unmet needs, Spirovant aims to revolutionize respiratory disease treatments through advanced gene therapy solutions. Their target clients include individuals suffering from cystic fibrosis and other respiratory conditions.Explore more
Spirovant Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Spirovant Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Spirovant Sciences launches new products
Spirovant Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Spirovant Sciences recently announced quarterly report
Funding: Get notified immidiatlly once Spirovant Sciences has new funding data
Check out if Spirovant Sciences is spiking on competitors!
Check if Spirovant Sciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Spirovant Sciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Spirovant Sciences
Recommended Actions
Reach out to Masked Content who joined Spirovant Sciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to Spirovant Sciences
Compare insights from companies similar to Spirovant Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Spirovant Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Spirovant Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Spirovant Sciences.
Spirovant Sciences Tech Stack
A closer look at the technologies used by Spirovant Sciences
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Event
Person-Based
Events, Search, Medical Research
Executive Move
Board of Directors
Executive Move
Board of Directors
Open Position
Spirovant Sciences News & Media
Sumitomo Pharma Subsidiary Companies in the U.S., Including Sumitovant and its Wholly Owned Subsidiaries, to Combine and Form Sumitomo Pharma America
NEW YORK, April 3, 2023 /PRNewswire/ -- Sumitovant Biopharma Ltd. ("Sumitovant") announced today that its parent company Sumitomo Pharma Co., Ltd. ("Sumitomo Pharma") will combine its wholly owned U.S. subsidiaries to form Sumitomo Pharma America, Inc. ("Sumitomo Pharma America")....Sumitomo Pharma Subsidiary Companies in the U.S., Including Sumitomo Pharma Oncology, to Combine and Form Sumitomo Pharma America
CAMBRIDGE, Mass., April 3, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a wholly owned subsidiary of Sumitomo Pharma Co. Ltd, announced today that it will combine with affiliate companies Sumitomo Pharma America Holdings, Inc., Sumitovant Biopharma Ltd., Myovant Sciences, Inc.,...Spirovant Launches State-of-the-Art Laboratory and Headquarters
The facilities are located in the center of Philadelphia's thriving life sciences corridor PHILADELPHIA, May 16, 2022 /PRNewswire/ -- Spirovant Sciences, a gene therapy company developing treatments for respiratory diseases, including cystic fibrosis (CF), announced today the launch of...Sumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021
LONDON and NEW YORK, Dec. 10, 2021 /PRNewswire/ -- Sumitovant Biopharma, Inc. today announced that its portfolio of four wholly-owned subsidiary companies (Urovant, Enzyvant, Altavant and Spirovant) and Myovant (NYSE: MYOV), a publicly listed company that is majority-owned by Sumitovant,...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Spirovant Sciences
Sign Up For FreeTo access detailed company insights
Spirovant Sciences is a biotechnology company specializing in the development of gene therapies for cystic fibrosis and other genetic lung diseases. The company utilizes its proprietary Adeno-Associated Virus (AAV) + Augmenter platform to create innovative treatments that address historical barriers in effective genetic therapies. With a focus on p... Read More
